Dormicum 15 mg tablets

Dormicum is a well-known pharmaceutical brand specializing in sedative and hypnotic medications, specifically containing the active ingredient Midazolam. It was originally developed and launched by the Swiss pharmaceutical giant Roche (F. Hoffmann-La Roche AG). The product is used globally in clinical settings for anesthesia induction and the treatment of severe sleep disturbances.

Today, the brand remains under the ownership of Roche, which is headquartered in Basel, Switzerland. As a research-focused healthcare company, Roche manufactures Dormicum in various facilities across Europe and other regions to supply international markets. In some regions, local subsidiaries or licensed distributors manage the commercialization, but Roche retains the ultimate brand ownership and oversight of the primary manufacturing standards.